Tag: Biomarker

Over the past few years, therapeutic advancements in conventional treatment paradigms have led to an increase in survival among cancer patients. Recent developments in the field of immuno-oncology, such as the introduction of several liquid biopsy techniques, adoptive T-cell therapies, and immune checkpoint inhibitor based therapies, have demonstrated significant potential, and some of the aforementioned

Over the years, several cancer biomarkers have been identified, which can be used to predict response to certain types of immunotherapy drugs. However, due to the inherent complexity of the immune microenvironment and differences in the genomic makeup of individual patients, most of these biomarkers in cancer have been proven to be insufficient in predicting